Anmeldung erfolgt in Kürze...
Details werden geladen...
Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs | The Manila Times
EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - Phase 3 protocol submitted with FDA feedback expected imminently; incremental data submitted to ENDO2026 and ASBMR
Ähnliche Seiten
FLINT Announces First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/08/tmt-newswire/globenewswire/flint-announces-first-quarter-2026-financial-results/2339092Vornado Announces First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/05/tmt-newswire/globenewswire/vornado-announces-first-quarter-2026-financial-results/2335430Navitas Semiconductor Announces First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/06/tmt-newswire/globenewswire/navitas-semiconductor-announces-first-quarter-2026-financial-results/2336571Timbercreek Financial Announces 2026 First Quarter Results | The Manila Times
https://www.manilatimes.net/2026/05/06/tmt-newswire/globenewswire/timbercreek-financial-announces-2026-first-quarter-results/2336658electroCore Announces First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/07/tmt-newswire/globenewswire/electrocore-announces-first-quarter-2026-financial-results/2337677